Possible new therapeutic approach in diabetes mellitus by inhibition of carnitine palmitoyltransferase 1 (CPT1).
Wolf
H P
HP
Research Centre, Byk Gulden Pharmaceuticals, Konstanz, Germany.
D002334:Carnitine O-Palmitoyltransferase / Q000037:antagonists & inhibitors*; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000201:enzymology; D004852:Epoxy Compounds / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use
D004852:Epoxy Compounds; D007004:Hypoglycemic Agents; D002334:Carnitine O-Palmitoyltransferase; C054207:etomoxir